skip to Main Content

Our Mission

IBT Bioservices is the contract research division of Integrated BioTherapeutics, Inc. (IBT). IBT Bioservices offers a strong client-oriented research and development service focused on our area of expertise, infectious diseases. Our team has extensive experience in antiviral and antibacterial screening and model development.

M. Javad Aman, PhD

Javad leads IBT and its innovative science programs. He is a distinguished researcher in viral and bacterial diseases with 125+ publications.

Rick Holtsberg, PhD
VP, Manufacturing & Bioanalytics

Rick leads IBT Bioservices’ assay & protein services group and develops IBT’s biochemical reagent portfolio. See Rick’s publications.

Robin Douglas
VP, Programs & Operations

Robin leads IBT Bioservices with its state-of-the-art infectious disease research capabilities and strong customer service focus.

Rajan Adhikari, PhD
Associate Director, Bacterial Therapeutics

Rajan investigates bacterial pathogens and leads antibacterial vaccine and therapeutic development programs. See Rajan’s publications.

Sergey Shulenin, PhD
Assistant Director, Protein Chemistry

Sergey works on assay development and protein expression. See Sergey’s publication’s.

Hong Vu

Manager, Analytical Assay Development

Hong leads IBT’s assay development, quality control testing and provides logistical support for IBT’s research and bioservice projects. See Hong’s publications.

Shweta Kailasan, PhD

Principal Scientist

Shweta leads IBT’s discovery program for antiviral and antibacterial vaccine & antibody therapeutics. Read Shweta’s publications.

Our Partners

Back To Top